phrykt

Kestra Medical Technologies, Ltd. (KMTS): who owns it and who trades it

As of Nov 16, 2026, KMTS insiders reported 54 open-market sales worth $15.5M and 1 purchase worth $200K in the last 12 months, with 42% of the sale value made under pre-set 10b5-1 plans. The largest seller was Brian Daniel Webster (Director), with $5.5M. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Kestra Medical Technologies

From the latest filings

Overall: about as much buying as selling. Insiders mostly sold. Funds mostly bought. Famous investors was close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns KMTS

110 funds and institutions reported KMTS shares worth $1.5B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is Bain Capital Investors LLC with 43.1%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

Bain Capital Investors LLC43.1%
FMR LLC (Fidelity)9.5%
T. Rowe Price Associates8.5%
Andera Partners4.7%
Yu Fan3.9%
Brown Advisory Inc3.3%
BlackRock, Inc.3.2%
Alliancebernstein L.P.2.5%
Eventide Asset Management, LLC2.5%
Vanguard Capital Management LLC2.0%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Bain Capital Investors LLC25.17M43.12%$640MNo change
FMR LLC (Fidelity)5.52M9.46%$141M-3%
T. Rowe Price Associates4.97M8.51%$126M-17%
Andera Partners2.73M4.67%$69.4M+1%
Yu Fan2.28M3.91%$58.1MNo change
Brown Advisory Inc1.91M3.27%$48.6M+11%
BlackRock, Inc.1.87M3.20%$47.5M+10%
Alliancebernstein L.P.1.48M2.53%$29.5M+12%
Eventide Asset Management, LLC1.45M2.48%$36.8M+0%
Vanguard Capital Management LLC1.18M2.01%$29.9M-3%
Franklin Resources Inc1.12M1.92%$28.6M-10%
Omega Fund Management, LLC1.02M1.75%$26MNo change
Hood River Capital Management LLC753,5291.29%$19.2M+15%
State Street Corp747,7031.28%$19M+11%
California State Teachers Retirement System686,4221.18%$27M+2366%
Geode Capital Management, LLC647,3801.11%$16.5M+13%
Point72 Asset Management, L.P.526,6260.90%$13.4M–
Federated Hermes, Inc.525,0000.90%$13.4MNo change
Next Century Growth Investors LLC458,5050.79%$11.7M+0%
Driehaus Capital Management LLC448,6080.77%$11.4M+0%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, KMTS insiders reported $200K of open-market purchases and $15.5M of sales. 42% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$200K
1 trades, 1 people
Sales, 12 months
$15.5M
54 trades, 11 people
Sales under a 10b5-1 plan
42%
Share of sale value
Latest trade
Nov 3, 2026
Filed Nov 5, 2026

Purchases and sales by month

$6.5M$6.5MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 3, 2026Timothy P. MoranChief Business OfficerSale3,192$29.56$94.4KForm 4
Oct 29, 2026Vaseem MahboobCFOSale plan4,788$30.60$147KForm 4
Oct 28, 2026Vaseem MahboobCFOSale plan39,903$30.48$1.2MForm 4
Oct 27, 2026Traci S UmbergerDirectorSale plan30,000$30.03$901KForm 4
Oct 27, 2026Vaseem MahboobCFOSale plan34,809$30.04$1MForm 4
Oct 21, 2026Traci S UmbergerDirectorSale plan96,404$27.15$2.6MForm 4
Oct 21, 2026Traci S UmbergerDirectorSale plan3,596$28.09$101KForm 4
Oct 20, 2026Brian Daniel WebsterDirectorSale plan13,316$29.52$393KForm 4
Oct 20, 2026Brian Daniel WebsterDirectorSale plan1,684$29.89$50.3KForm 4
Sep 30, 2026Raymond W CohenDirectorSale3,330$29.28$97.5KForm 4
Sep 21, 2026Elizabeth KwoDirectorSale4,010$24.26$97.3KForm 4
Sep 8, 2026Jeffrey Lawrence SchwartzDirectorSale3,890$25.18$98KForm 4
Sep 8, 2026Conor HanleyDirectorSale5,694$25.25$144KForm 4
Sep 8, 2026Kevin C ReillyDirectorSale2,932$25.13$73.7KForm 4
Sep 8, 2026Mary Kay LadoneDirectorSale3,908$25.20$98.5KForm 4
Aug 17, 2026Brian Daniel WebsterDirectorSale15,000$27.48$412KForm 4
Aug 7, 2026Vaseem MahboobCFOSale500$26.33$13.2KForm 4
Aug 7, 2026Vaseem MahboobCFOSale25,787$25.87$667KForm 4
Aug 4, 2026Alfred J Ford JrChief Commercial OfficerSale6,275$24.09$151KForm 4
Aug 4, 2026Vaseem MahboobCFOSale3,915$25.17$98.5KForm 4
Aug 4, 2026Vaseem MahboobCFOSale3,080$24.06$74.1KForm 4
Aug 4, 2026Traci S UmbergerDirectorSale3,580$24.04$86.1KForm 4
Aug 4, 2026Brian Daniel WebsterDirectorSale48,625$24.47$1.2MForm 4
Aug 4, 2026Brian Daniel WebsterDirectorSale442$25.98$11.5KForm 4
Aug 4, 2026Brian Daniel WebsterDirectorSale2,833$25.16$71.3KForm 4
Aug 3, 2026Timothy P. MoranChief Business OfficerSale2,380$23.76$56.5KForm 4
Aug 3, 2026Alfred J Ford JrChief Commercial OfficerSale13,015$23.90$311KForm 4
Aug 3, 2026Vaseem MahboobCFOSale5,391$23.80$128KForm 4
Aug 3, 2026Traci S UmbergerDirectorSale7,590$23.86$181KForm 4
Aug 3, 2026Brian Daniel WebsterDirectorSale13,017$23.92$311KForm 4
Jul 31, 2026Timothy P. MoranChief Business OfficerSale8,759$22.61$198KForm 4
Jul 31, 2026Alfred J Ford JrChief Commercial OfficerSale8,681$22.61$196KForm 4
Jul 31, 2026Vaseem MahboobCFOSale8,817$22.61$199KForm 4
Jul 31, 2026Traci S UmbergerDirectorSale8,752$22.60$198KForm 4
Jul 31, 2026Brian Daniel WebsterDirectorSale8,948$22.60$202KForm 4
Jul 30, 2026Timothy P. MoranChief Business OfficerSale4,117$22.77$93.7KForm 4
Jul 30, 2026Alfred J Ford JrChief Commercial OfficerSale5,936$22.76$135KForm 4
Jul 30, 2026Vaseem MahboobCFOSale3,980$22.75$90.5KForm 4
Jul 30, 2026Traci S UmbergerDirectorSale5,887$22.74$134KForm 4
Jul 30, 2026Brian Daniel WebsterDirectorSale7,857$22.72$179KForm 4
Jul 15, 2026Brian Daniel WebsterDirectorSale11,216$22.01$247KForm 4
Jul 15, 2026Brian Daniel WebsterDirectorSale3,000$24.00$72KForm 4
Jul 15, 2026Brian Daniel WebsterDirectorSale784$22.63$17.7KForm 4
Jun 15, 2026Brian Daniel WebsterDirectorSale15,000$20.81$312KForm 4
May 15, 2026Brian Daniel WebsterDirectorSale6,845$21.46$147KForm 4
May 15, 2026Brian Daniel WebsterDirectorSale8,155$20.53$167KForm 4
Apr 15, 2026Brian Daniel WebsterDirectorSale15,000$20.04$301KForm 4
Mar 26, 2026Raymond W CohenDirectorPurchase10,000$19.98$200KForm 4
Mar 17, 2026Brian Daniel WebsterDirectorSale15,000$20.27$304KForm 4
Feb 17, 2026Brian Daniel WebsterDirectorSale3,272$26.29$86KForm 4
Feb 17, 2026Brian Daniel WebsterDirectorSale93$27.18$2.5KForm 4
Feb 17, 2026Brian Daniel WebsterDirectorSale11,635$25.39$295KForm 4
Jan 15, 2026Brian Daniel WebsterDirectorSale15,000$22.80$342KForm 4
Dec 29, 2025Traci S UmbergerDirectorSale10,500$26.69$280KForm 4
Dec 29, 2025Brian Daniel WebsterDirectorSale15,000$26.59$399KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Brian Daniel WebsterSee Remarks, Director–$5.5MOct 20, 2026
Traci S UmbergerSee Remarks, Director–$4.5MOct 27, 2026
Vaseem MahboobChief Financial Officer–$3.7MOct 29, 2026
Alfred J Ford JrChief Commercial Officer–$794KAug 4, 2026
Timothy P. MoranChief Business Officer–$443KNov 3, 2026
Raymond W CohenDirector$200K$97.5KSep 30, 2026
Conor HanleyDirector–$144KSep 8, 2026
Mary Kay LadoneDirector–$98.5KSep 8, 2026
Jeffrey Lawrence SchwartzDirector, 10% owner–$98KSep 8, 2026
Elizabeth KwoDirector–$97.3KSep 21, 2026
Kevin C ReillyDirector–$73.7KSep 8, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

KMTS short interest

Moderate short interest. 6.9% of KMTS shares are sold short: about 1 share in 15. Over the last 12 reports the number of shares short went up 25%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 4.10M KMTS shares were sold short, 6.9% of the shares outstanding, up 19.7% from the report before. At the average daily volume of 503,879 shares, buying them all back would take about 8.2 trading days (days to cover).

Shares short, % of all shares

6.89%May 15Oct 307.19%

Days to cover

8.2May 15Oct 3013.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20264.10M6.89%+20%503,8798.2
Oct 15, 20263.43M5.76%+5%279,04112.3
Sep 30, 20263.28M5.50%+5%449,9737.3
Sep 15, 20263.12M5.24%+5%374,4628.3
Aug 31, 20262.97M5.07%-1%240,36112.4
Aug 14, 20263.02M5.15%-8%337,0268.9
Jul 31, 20263.29M5.62%+6%323,41210.2
Jul 15, 20263.10M5.28%-8%510,2816.1
Jun 30, 20263.36M5.76%+15%457,5777.3
Jun 15, 20262.93M5.02%+2%326,7039.0
May 29, 20262.87M4.92%-12%249,94011.5
May 15, 20263.28M5.62%-5%265,60212.3

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Kestra Medical Technologies company events

Kestra Medical Technologies filed 7 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Sep 14, 2026.

  1. Sep 14, 2026ResultsReleased financial results. Filing
  2. Sep 10, 2026VoteReported shareholder vote results. Filing
  3. Jul 14, 2026AgreementKestra Medical Technologies, Ltd., its wholly-owned subsidiary, Kestra Medical Technologies, Inc. and other credit parties thereto (collectively with the Borrower and the Company, the “Credit Parties”), entered into a loan agreement with BPCR Limited Partnership and BioPharma Credit Investments V… Filing
  4. Mar 17, 2026ResultsReleased financial results. Filing
  5. Dec 11, 2025ResultsReleased financial results. Filing
  6. Dec 4, 2025AgreementKestra Medical Technologies, Ltd., a Bermuda exempted company entered into an Underwriting Agreement with BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein, related to an underwritten… Filing
  7. Dec 1, 2025ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Kestra Medical Technologies financials

Famous investors that hold KMTS

2 of the 50 well-known investors we track reported holding KMTS in their latest 13F filing. The largest position is Steve Cohen's, worth $13.8M.

FundQuarterSharesValueOf portfolioChange
Steve Cohen · Point72 Asset ManagementQ3 2026489,279$13.8M0.0%-7%
Israel Englander · Millennium ManagementQ3 2026211,418$6M0.0%+29%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Kestra Medical Technologies, Ltd. (KMTS) stock

Who owns the most KMTS stock?

The largest reported owner of Kestra Medical Technologies, Ltd. (KMTS) is Bain Capital Investors LLC, with 43.1% of the company. In total, 110 funds and institutions reported holding KMTS at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are KMTS insiders buying or selling?

In the last 12 months, KMTS insiders reported 1 open-market purchase worth $200K and 54 sales worth $15.5M. The latest trade was on Nov 3, 2026. See every trade.

What is the short interest in KMTS?

As of Oct 30, 2026, 4.10M KMTS shares were sold short, 6.9% of the shares outstanding, up 19.7% from the report before. At the average daily volume of 503,879 shares, buying them all back would take about 8.2 trading days (days to cover). See the history.

Which famous investors hold KMTS?

2 of the 50 well-known investors we track reported KMTS in their latest 13F filing, including Steve Cohen, Israel Englander. The largest position is worth $13.8M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.